Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessas Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist
July 04, 2025 03:00 ET Â | Source: Nxera Pharma Tokyo, Japan and…
Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team
Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to…
Bound’s Publishing Course is building the next generation of creative professionals
MUMBAI, India, July 3, 2025 /PRNewswire/ -- Bound, India's leading creative education…
ASIA’S 50 BEST BARS 2025 REVEALS THE ESTABLISHMENTS RANKED ON THE EXTENDED 51-100 LIST
LONDON, July 3, 2025 /PRNewswire/ -- Casting a spotlight on an expanded…
Planisware accelerates its development in Asia and announces the opening of an office in Seoul
Planisware accelerates its development in Asia and announces the opening of an…
Azentio appoints Harikrishnan Venkataramanan as President – ERP to spearhead next phase of innovation and growth
SINGAPORE, July 3, 2025 /PRNewswire/ -- Azentio Software ("Azentio"), a leading technology…
Melento, Powered by SignDesk, Announces Strategic Expansion into Latin America
Melento, powered by SignDesk, a global leader in intelligent contract lifecycle management…
Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors
July 02, 2025 06:00 ET Â | Source: Instil Bio US phase 1…
Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy
July 02, 2025 03:00 ET Â | Source: Belite Bio, Inc -Â 500…
OSE Immunotherapeutics met jour linformation sur les procdures en cours
OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2,…